205 related articles for article (PubMed ID: 33157165)
1. Analysis of a within-host HIV/HTLV-I co-infection model with immunity.
Elaiw AM; AlShamrani NH
Virus Res; 2021 Apr; 295():198204. PubMed ID: 33157165
[TBL] [Abstract][Full Text] [Related]
2. Modeling and analysis of a within-host HIV/HTLV-I co-infection.
Elaiw AM; AlShamrani NH
Bol Soc Mat Mex; 2021; 27(2):38. PubMed ID: 33814640
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of HIV-1/HTLV-I Co-Infection Model with Humoral Immunity and Cellular Infection.
AlShamrani NH; Alshaikh MA; Elaiw AM; Hattaf K
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016341
[TBL] [Abstract][Full Text] [Related]
4. Analysis of an HTLV/HIV dual infection model with diffusion.
Elaiw AM; AlShamrani NH
Math Biosci Eng; 2021 Oct; 18(6):9430-9473. PubMed ID: 34814353
[TBL] [Abstract][Full Text] [Related]
5. Stability of HTLV/HIV dual infection model with mitosis and latency.
Elaiw AM; AlShamrani NH
Math Biosci Eng; 2021 Jan; 18(2):1077-1120. PubMed ID: 33757177
[TBL] [Abstract][Full Text] [Related]
6. Stability of an HTLV-HIV coinfection model with multiple delays and CTL-mediated immunity.
AlShamrani NH
Adv Differ Equ; 2021; 2021(1):270. PubMed ID: 34054935
[TBL] [Abstract][Full Text] [Related]
7. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
[TBL] [Abstract][Full Text] [Related]
8. Co-Infection and Cancer: Host-Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses.
Mulherkar TH; Gómez DJ; Sandel G; Jain P
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146843
[TBL] [Abstract][Full Text] [Related]
9. T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).
Casseb J; Posada-Vergara MP; Montanheiro P; Fukumori LM; Olah I; Smid J; Duarte AJ; Penalva de Oliveira AC
Rev Inst Med Trop Sao Paulo; 2007; 49(4):231-3. PubMed ID: 17823752
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread.
Kalinichenko S; Komkov D; Mazurov D
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062355
[TBL] [Abstract][Full Text] [Related]
11. Stability analysis of general delayed HTLV-I dynamics model with mitosis and CTL immunity.
Elaiw AM; Shflot AS; Hobiny AD
Math Biosci Eng; 2022 Aug; 19(12):12693-12729. PubMed ID: 36654018
[TBL] [Abstract][Full Text] [Related]
12. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
[TBL] [Abstract][Full Text] [Related]
13. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
14. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes.
Hanon E; Hall S; Taylor GP; Saito M; Davis R; Tanaka Y; Usuku K; Osame M; Weber JN; Bangham CR
Blood; 2000 Feb; 95(4):1386-92. PubMed ID: 10666215
[TBL] [Abstract][Full Text] [Related]
15. HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment.
Futsch N; Mahieux R; Dutartre H
Viruses; 2017 Dec; 10(1):. PubMed ID: 29267225
[TBL] [Abstract][Full Text] [Related]
16. Clonality of HIV-1- and HTLV-1-Infected Cells in Naturally Coinfected Individuals.
Katsuya H; Cook LBM; Rowan AG; Melamed A; Turpin J; Ito J; Islam S; Miyazato P; Jek Yang Tan B; Matsuo M; Miyakawa T; Nakata H; Matsushita S; Taylor GP; Bangham CRM; Kimura S; Satou Y
J Infect Dis; 2022 Jan; 225(2):317-326. PubMed ID: 33844021
[TBL] [Abstract][Full Text] [Related]
17. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
[TBL] [Abstract][Full Text] [Related]
18. Pseudotyping of HIV-1 with Human T-Lymphotropic Virus 1 (HTLV-1) Envelope Glycoprotein during HIV-1-HTLV-1 Coinfection Facilitates Direct HIV-1 Infection of Female Genital Epithelial Cells: Implications for Sexual Transmission of HIV-1.
Tang Y; George AM; Petrechko O; Nouvet FJ; Sweet SD; Tanaka Y; Imbiakha BS; Jiang G; Gao W; Anastos K; Hildreth JEK
mSphere; 2018 Apr; 3(2):. PubMed ID: 29624497
[TBL] [Abstract][Full Text] [Related]
19. Neurological aspects of HIV/human T lymphotropic virus coinfection.
Tulius Silva M; de Melo Espíndola O; Bezerra Leite AC; Araújo A
AIDS Rev; 2009; 11(2):71-8. PubMed ID: 19529747
[TBL] [Abstract][Full Text] [Related]
20. Human T-Lymphotropic virus type 1 and human immunodeficiency virus co-infection in rural Gabon.
Mouinga-Ondémé A; Boundenga L; Koumba Koumba IP; Idam Mamimandjiami A; Diané A; Engone-Ondo JD; Djuicy DD; Sica J; Mombo LE; Gessain A; Aghokeng Fobang A
PLoS One; 2022; 17(7):e0271320. PubMed ID: 35867643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
